Annual CFI
-$2.10 M
+$20.82 M+90.83%
31 December 2023
Summary:
Fortress Biotech annual cash flow from investing activities is currently -$2.10 million, with the most recent change of +$20.82 million (+90.83%) on 31 December 2023. During the last 3 years, it has risen by +$5.06 million (+70.64%). FBIO annual CFI is now -105.19% below its all-time high of $40.51 million, reached on 31 December 2021.FBIO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$0.00
$0.000.00%
30 September 2024
Summary:
Fortress Biotech quarterly cash flow from investing activities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has dropped by -$5.00 million (-100.00%). FBIO quarterly CFI is now -100.00% below its all-time high of $53.35 million, reached on 31 December 2021.FBIO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$63.00 K
-$5.00 M-101.28%
30 September 2024
Summary:
Fortress Biotech TTM cash flow from investing activities is currently -$63.00 thousand, with the most recent change of -$5.00 million (-101.28%) on 30 September 2024. Over the past year, it has increased by +$2.37 million (+97.41%). FBIO TTM CFI is now -100.14% below its all-time high of $46.39 million, reached on 30 June 2019.FBIO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FBIO Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +90.8% | -100.0% | +97.4% |
| 3 y3 years | +70.6% | +100.0% | +99.6% |
| 5 y5 years | -111.2% | +100.0% | -100.2% |
FBIO Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -105.2% | +90.8% | -100.0% | +100.0% | -100.2% | +99.7% |
| 5 y | 5 years | -105.2% | +90.8% | -100.0% | +100.0% | -100.2% | +99.7% |
| alltime | all time | -105.2% | +94.8% | -100.0% | +100.0% | -100.1% | +99.9% |
Fortress Biotech Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $0.00(0.0%) | -$63.00 K(-101.3%) |
| June 2024 | - | $0.00(0.0%) | $4.94 M(+70.4%) |
| Mar 2024 | - | $0.00(-100.0%) | $2.90 M(-237.8%) |
| Dec 2023 | -$2.10 M(-90.8%) | -$63.00 K(-101.3%) | -$2.10 M(-13.5%) |
| Sept 2023 | - | $5.00 M(-345.2%) | -$2.43 M(-70.8%) |
| June 2023 | - | -$2.04 M(-59.2%) | -$8.32 M(+26.3%) |
| Mar 2023 | - | -$5.00 M(+1178.8%) | -$6.59 M(-71.3%) |
| Dec 2022 | -$22.93 M(-156.6%) | -$391.00 K(-56.2%) | -$22.93 M(-174.4%) |
| Sept 2022 | - | -$893.00 K(+190.9%) | $30.82 M(+27.5%) |
| June 2022 | - | -$307.00 K(-98.6%) | $24.17 M(+23.1%) |
| Mar 2022 | - | -$21.34 M(-140.0%) | $19.64 M(-51.5%) |
| Dec 2021 | $40.51 M(-665.5%) | $53.35 M(-807.5%) | $40.51 M(-381.2%) |
| Sept 2021 | - | -$7.54 M(+55.8%) | -$14.41 M(+49.7%) |
| June 2021 | - | -$4.84 M(+956.8%) | -$9.62 M(+64.6%) |
| Mar 2021 | - | -$458.00 K(-70.8%) | -$5.85 M(-18.4%) |
| Dec 2020 | -$7.16 M(-135.6%) | -$1.57 M(-43.2%) | -$7.16 M(+35.5%) |
| Sept 2020 | - | -$2.76 M(+159.5%) | -$5.29 M(-15.8%) |
| June 2020 | - | -$1.06 M(-40.1%) | -$6.28 M(+7.8%) |
| Mar 2020 | - | -$1.78 M(-672.9%) | -$5.83 M(-129.0%) |
| Dec 2019 | $20.10 M(+6.8%) | $310.00 K(-108.3%) | $20.10 M(-39.7%) |
| Sept 2019 | - | -$3.75 M(+513.7%) | $33.31 M(-28.2%) |
| June 2019 | - | -$611.00 K(-102.5%) | $46.39 M(+3.5%) |
| Mar 2019 | - | $24.15 M(+78.6%) | $44.81 M(+138.1%) |
| Dec 2018 | $18.82 M(-146.8%) | $13.52 M(+44.9%) | $18.82 M(+69.9%) |
| Sept 2018 | - | $9.33 M(-526.3%) | $11.08 M(-148.0%) |
| June 2018 | - | -$2.19 M(+19.0%) | -$23.09 M(-43.9%) |
| Mar 2018 | - | -$1.84 M(-131.9%) | -$41.12 M(+2.2%) |
| Dec 2017 | -$40.22 M | $5.78 M(-123.3%) | -$40.22 M(-15.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2017 | - | -$24.84 M(+22.8%) | -$47.31 M(+133.0%) |
| June 2017 | - | -$20.22 M(+2046.8%) | -$20.30 M(+372.3%) |
| Mar 2017 | - | -$942.00 K(-27.8%) | -$4.30 M(-29.1%) |
| Dec 2016 | -$6.06 M(-176.9%) | -$1.30 M(-160.2%) | -$6.06 M(-117.6%) |
| Sept 2016 | - | $2.17 M(-151.4%) | $34.47 M(+213.3%) |
| June 2016 | - | -$4.22 M(+56.0%) | $11.00 M(-18.3%) |
| Mar 2016 | - | -$2.70 M(-106.9%) | $13.47 M(+70.8%) |
| Dec 2015 | $7.88 M(-133.9%) | $39.22 M(-284.1%) | $7.88 M(-114.6%) |
| Sept 2015 | - | -$21.30 M(+1117.8%) | -$54.01 M(+64.9%) |
| June 2015 | - | -$1.75 M(-78.9%) | -$32.76 M(+4.6%) |
| Mar 2015 | - | -$8.29 M(-63.5%) | -$31.31 M(+34.5%) |
| Dec 2014 | -$23.27 M(>+9900.0%) | -$22.68 M(>+9900.0%) | -$23.27 M(+3804.9%) |
| Sept 2014 | - | -$50.00 K(-83.1%) | -$596.00 K(+27.6%) |
| June 2014 | - | -$295.00 K(+18.0%) | -$467.00 K(+7.1%) |
| Mar 2014 | - | -$250.00 K(>+9900.0%) | -$436.00 K(+131.9%) |
| Dec 2013 | -$188.00 K(-32.6%) | -$1000.00(-101.3%) | -$188.00 K(-59.7%) |
| Sept 2013 | - | $79.00 K(-129.9%) | -$466.00 K(-14.5%) |
| June 2013 | - | -$264.00 K(>+9900.0%) | -$545.00 K(+94.0%) |
| Mar 2013 | - | -$2000.00(-99.3%) | -$281.00 K(+0.7%) |
| Dec 2012 | -$279.00 K(-92.7%) | -$279.00 K(<-9900.0%) | -$279.00 K(<-9900.0%) |
| Sept 2012 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2012 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2012 | - | $0.00(0.0%) | -$34.00 K(-99.1%) |
| Dec 2011 | -$3.84 M(>+9900.0%) | $0.00(0.0%) | -$3.84 M(0.0%) |
| Sept 2011 | - | $0.00(-100.0%) | -$3.84 M(0.0%) |
| June 2011 | - | -$34.00 K(-99.1%) | -$3.84 M(+0.9%) |
| Mar 2011 | - | -$3.81 M | -$3.81 M |
| Dec 2010 | -$13.00 K | - | - |
FAQ
- What is Fortress Biotech annual cash flow from investing activities?
- What is the all time high annual CFI for Fortress Biotech?
- What is Fortress Biotech annual CFI year-on-year change?
- What is Fortress Biotech quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Fortress Biotech?
- What is Fortress Biotech quarterly CFI year-on-year change?
- What is Fortress Biotech TTM cash flow from investing activities?
- What is the all time high TTM CFI for Fortress Biotech?
- What is Fortress Biotech TTM CFI year-on-year change?
What is Fortress Biotech annual cash flow from investing activities?
The current annual CFI of FBIO is -$2.10 M
What is the all time high annual CFI for Fortress Biotech?
Fortress Biotech all-time high annual cash flow from investing activities is $40.51 M
What is Fortress Biotech annual CFI year-on-year change?
Over the past year, FBIO annual cash flow from investing activities has changed by +$20.82 M (+90.83%)
What is Fortress Biotech quarterly cash flow from investing activities?
The current quarterly CFI of FBIO is $0.00
What is the all time high quarterly CFI for Fortress Biotech?
Fortress Biotech all-time high quarterly cash flow from investing activities is $53.35 M
What is Fortress Biotech quarterly CFI year-on-year change?
Over the past year, FBIO quarterly cash flow from investing activities has changed by -$5.00 M (-100.00%)
What is Fortress Biotech TTM cash flow from investing activities?
The current TTM CFI of FBIO is -$63.00 K
What is the all time high TTM CFI for Fortress Biotech?
Fortress Biotech all-time high TTM cash flow from investing activities is $46.39 M
What is Fortress Biotech TTM CFI year-on-year change?
Over the past year, FBIO TTM cash flow from investing activities has changed by +$2.37 M (+97.41%)